300255 logo

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Stock Price

SZSE:300255 Community·CN¥61.5b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

300255 Share Price Performance

CN¥66.96
47.72 (248.02%)
CN¥66.96
47.72 (248.02%)
Price CN¥66.96

300255 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk with imperfect balance sheet.

3 Risks
0 Rewards

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Key Details

CN¥928.0m

Revenue

CN¥867.7m

Cost of Revenue

CN¥60.3m

Gross Profit

CN¥361.9m

Other Expenses

-CN¥301.6m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.33
6.50%
-32.50%
169.6%
View Full Analysis

About 300255

Founded
2000
Employees
1254
CEO
Xiaodong Gao
WebsiteView website
www.hbcsbio.com

Hebei Changshan Biochemical Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of crude heparin, heparin raw materials, and heparin preparations for the treatment of cardiovascular and cerebrovascular diseases in China and internationally. The company offers crude heparin sodium, heparin sodium API, heparin sodium injections, low molecular weight heparin calcium injections, enoxaparin sodium injections, nandroparin calcium injection, dalteparin sodium API and injections, and other products. The company was founded in 2000 and is headquartered in Shijiazhuang, China.

Recent 300255 News & Updates

Recent updates

No updates